Presentation is loading. Please wait.

Presentation is loading. Please wait.

Behçet´s Disease Christoph Deuter Centre for Ophthalmology, University Hospital, Tuebingen, Germany.

Similar presentations


Presentation on theme: "Behçet´s Disease Christoph Deuter Centre for Ophthalmology, University Hospital, Tuebingen, Germany."— Presentation transcript:

1 Behçet´s Disease Christoph Deuter Centre for Ophthalmology, University Hospital, Tuebingen, Germany

2 History  25, female, German origin  emergency referral from external hospital  OU: retinitis, visual impairment, visual field defects

3 General History  common cold with fever, 39°C,  generalized exanthema,  purulent genital ulcerations,  dizziness  treatment: Aciclovir and Ganciclovir intravenously, low dose prednisolone

4 First Presentation – Ocular Examination VA: OD 20/125, OS 20/50 VA: OD 20/125, OS 20/50 anterior chamber: unremarkable anterior chamber: unremarkable IOP: 16/16 mmHg IOP: 16/16 mmHg

5 First Presentation - Fundus  OU: retinal infiltration of macular region

6 First Presentation - Investigations  oral and genital ulcers  papulopustulosis  retinitis / retinal vasculitis both eyes  HLA-B51 positive  pathergy test negative  bilateral vestibularis affection

7 Diagnosis  complete Behçet´s Disease with ocular and neurological involvement  based on:  clinical findings  fullfills the Classification Criteria of the International Study Group (1990)

8 Treatment Aciclovir and Ganciclovir discontinued Aciclovir and Ganciclovir discontinued IFN alpha-2a (4.5 mio IU per day) IFN alpha-2a (4.5 mio IU per day) Prednisolone (10 mg per day continued) Prednisolone (10 mg per day continued)

9 Follow up – After 2 Weeks OD VA 20/50 OS VA 20/20

10 Follow up – After 6 Months  VA: OD 20/20, OS 20/20  free of recurrences  current treatment  IFN alpha-2a 3 mio IU every 2nd day  prednisolone 5 mg /day

11 Follow up – After 6 Months  normal fundus without signs of inflammation

12 Follow up – After 5 Years  VAA: OD 20/25, OS 20/20  free of recurrences  current treatment  off IFN alpha-2a since 4 years,  prednisolone 5 mg /day

13 Final follow up – After 5 years  Normal fundus, no signs of inflammation

14 Conclusion Typical for uveitis with Behcet´s Disease are retinal infiltrations, occlusive retinal vasculitis Typical for uveitis with Behcet´s Disease are retinal infiltrations, occlusive retinal vasculitis In case of retinal involvement it is recommended to start biological treatment with TNF-alpha blocking agents or alpha-interferon In case of retinal involvement it is recommended to start biological treatment with TNF-alpha blocking agents or alpha-interferon This may result in long term remission even after stop of treatment This may result in long term remission even after stop of treatment


Download ppt "Behçet´s Disease Christoph Deuter Centre for Ophthalmology, University Hospital, Tuebingen, Germany."

Similar presentations


Ads by Google